###begin article-title 0
###xml 34 40 <span type="species:ncbi:10090">Murine</span>
IL-10 Signaling Blockade Controls Murine West Nile Virus Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: FB EF. Performed the experiments: FB TT FQ PW DG. Analyzed the data: FB TT FQ PW EF. Contributed reagents/materials/analysis tools: FB MK TMC RRM RAF EF. Wrote the paper: FB TT EF.
###end p 1
###begin p 2
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 382 385 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 563 566 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 558 566 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 759 766 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
###xml 17 20 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 228 231 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 289 292 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 320 323 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 492 495 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 617 620 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 745 748 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 841 844 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 980 983 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
West Nile virus (WNV), a mosquito-borne single-stranded RNA flavivirus, can cause significant human morbidity and mortality. Our data show that interleukin-10 (IL-10) is dramatically elevated both in vitro and in vivo following WNV infection. Consistent with an etiologic role of IL-10 in WNV pathogenesis, we find that WNV infection is markedly diminished in IL-10 deficient (IL-10-/-) mice, and pharmacologic blockade of IL-10 signaling by IL-10 neutralizing antibody increases survival of WNV-infected mice. Increased production of antiviral cytokines in IL-10-/- mice is associated with more efficient control of WNV infection. Moreover, CD4+ T cells produce copious amounts of IL-10, and may be an important cellular source of IL-10 during WNV infection in vivo. In conclusion, IL-10 signaling plays a negative role in immunity against WNV infection, and blockade of IL-10 signaling by genetic or pharmacologic means helps to control viral infection, suggesting a novel anti-WNV therapeutic strategy.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 741 742 741 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
###xml 17 20 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 151 154 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 255 261 <span type="species:ncbi:9606">humans</span>
###xml 363 366 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 428 431 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 615 618 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 696 699 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 796 799 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1149 1152 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
West Nile virus (WNV), a mosquito-transmitted RNA virus, is a worldwide cause of severe human and animal infection. Mammalian host immune responses to WNV infection are not completely understood and a vaccine or specific therapy is unavailable for use in humans. In the present study, we investigated the putative regulatory role of interleukin-10 (IL-10) during WNV infection in mice. We found that IL-10 signaling facilitates WNV infection and suppresses antiviral cytokine production in response to viral infection. Interestingly, blockade of IL-10 signaling by IL-10 neutralizing antibody increases survival of WNV-infected mice, suggesting a potentially novel therapeutic strategy to combat WNV infection. In addition, we found that CD4+ T cells produce a significant amount of IL-10 during WNV infection, providing a more accurate cellular target for IL-10 signaling inhibition. IL-10 also plays a critical role in suppression of excessive inflammation and immunopathology caused by autoimmune diseases or host immune system responses to infections; therefore, safety and efficacy of IL-10 signaling blockade as a therapeutic strategy against WNV infection deserves consideration.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Petersen1">[1]</xref>
###xml 605 608 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Gould1">[2]</xref>
###xml 0 3 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 66 72 <span type="species:ncbi:9606">humans</span>
###xml 123 126 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 196 202 <span type="species:ncbi:9606">humans</span>
###xml 204 210 <span type="species:ncbi:9796">horses</span>
###xml 309 314 <span type="species:ncbi:9606">human</span>
###xml 598 604 <span type="species:ncbi:9606">humans</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 642 645 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 733 738 <span type="species:ncbi:9606">human</span>
WNV has caused severe morbidity and mortality in both animals and humans since it first appeared in North America in 1999. WNV is maintained in an enzootic cycle between mosquitoes and birds; but humans, horses and other mammals can be inadvertently infected by mosquitoes that carry the virus. Although most human infections are asymptomatic, the elderly and individuals with a compromised immune system are particularly susceptible to life-threatening neurologic disease [1]. Viral pathogenesis is not completely understood, and a vaccine or specific therapy has not yet been approved for use in humans [2]. Experimental mice infected with WNV develop a systemic infection that results in encephalitis and death, thereby mimicking human neuroinvasive disease and providing a valuable model system within which to study viral pathogenesis and immunity.
###end p 6
###begin p 7
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Moore1">[3]</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Gazzinelli1">[5]</xref>
###xml 715 718 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Hsu1">[6]</xref>
###xml 955 958 955 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 959 962 959 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Maris1">[9]</xref>
###xml 1207 1210 1207 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 1211 1214 1211 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brooks1">[8]</xref>
###xml 576 594 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 760 794 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
###xml 796 800 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
Mammalian T helper 1 (Th1) cytokine responses are essential for eradicating invading intracellular pathogens. However, if these responses are too strong, bystander effects may damage the host. Interleukin-10 (IL-10), a pleiotropic cytokine, plays a crucial immunosuppressive role during excessive Th1 responses, and can thereby protect the host from potentially damaging immunopathology [3]-[5]. However, excessive IL-10 production suppresses host immune responses and can inadvertently facilitate the ability of intracellular pathogens to escape host innate immune defenses. Epstein-Barr virus (EBV) takes advantage of the immunomodulatory effects of IL-10 by expressing a viral homolog of IL-10 during infections [6]. In addition, recent studies showed that lymphocytic choriomeningitis virus (LCMV) clone 13 elicits high levels of IL-10 production from the infected host, thereby resulting in exhaustion of virus-specific T cells and viral persistence [7]-[9]. Interestingly, neutralization of IL-10 during persistent viral infection leads to recovery of virus-specific T cell responses and reduction of viral load, suggesting a potential therapy to restore T cell function and prevent viral persistence [7],[8].
###end p 7
###begin p 8
###xml 132 136 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Purtha1">[10]</xref>
###xml 137 141 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Tobler1">[14]</xref>
###xml 175 176 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 176 180 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Sitati1">[15]</xref>
###xml 181 185 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brien1">[16]</xref>
###xml 190 191 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 199 203 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Shrestha2">[17]</xref>
###xml 204 208 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Shrestha4">[21]</xref>
###xml 241 245 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Welte1">[22]</xref>
###xml 246 250 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang3">[24]</xref>
###xml 312 315 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Moore1">[3]</xref>
###xml 361 365 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Bogdan1">[25]</xref>
###xml 366 370 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Donnelly1">[28]</xref>
###xml 381 385 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Minty1">[29]</xref>
###xml 386 390 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-McKenzie1">[30]</xref>
###xml 98 101 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 291 294 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 513 516 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 629 632 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 711 714 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Type I Interferon (IFN) and Th1 cytokines, including IFN-gamma, provide immediate defense against WNV replication and dissemination [10]-[14]. Cellular immunity, including CD4+[15],[16], CD8+ T cell [17]-[21] and gammadelta T cell responses [22]-[24], also participate in host recovery from WNV infection. IL-10 [3] and other regulatory cytokines, such as IL-4 [25]-[28] and IL-13 [29],[30] have been documented to suppress Th1 responses. The role of these regulatory cytokines in modulating Th1 responses during WNV pathogenesis is, however, not completely understood. In the current study, we investigated the role of IL-10 in WNV infection, and our results suggest a promising therapeutic strategy to combat WNV infection through blockade of IL-10 signaling.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 52 55 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Expression of IL-10 is dramatically increased after WNV infection
###end title 10
###begin p 11
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-4</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-13</italic>
###xml 481 489 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;</italic>
###xml 597 602 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 832 837 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 908 916 905 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 918 928 915 925 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 A</bold>
###xml 933 934 930 931 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 918 934 915 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g001"><bold>Figure 1 A</bold> and <bold>B</bold></xref>
###xml 980 993 977 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10 in vivo</italic>
###xml 1195 1197 1192 1194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1199 1203 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Dai1">[31]</xref>
###xml 1204 1208 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Town1">[33]</xref>
###xml 1273 1283 1270 1280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 C</bold>
###xml 1273 1283 1270 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g001"><bold>Figure 1 C</bold></xref>
###xml 1286 1293 1283 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 34 37 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 247 250 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 753 756 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 894 897 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1097 1100 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1567 1570 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
To study host immune responses to WNV infection, we performed cytokine expression polymerase chain reaction (PCR) arrays in which cytokine expression profiles were analyzed in thioglycollate-elicited peritoneal macrophages from C57BL/6 mice after WNV infection (multiplicity of infection [MOI] = 1). We observed that IL-10 expression was up-regulated 4- fold at 5 h and 90-fold at 24 h post-infection (p.i.), while expression of IL-4, IL-13 and another immunosuppressive cytokine, TGF-beta, were not significantly altered at both time points (data not shown). To confirm this finding, we measured IL-10 mRNA by reverse transcription quantitative real-time PCR (Q-PCR) and quantified secreted IL-10 protein in cell culture media from primary cultures of WNV-infected macrophages by ELISA. Both Q-PCR and ELISA results confirmed that IL-10 mRNA and IL-10 protein were markedly up-regulated after WNV infection in vitro (Figure 1 A and B). To further evaluate expression kinetics of IL-10 in vivo, we intraperitoneally (i.p.) infected a group of C57BL/6 mice with 2,000 plaque forming units (pfu) of WNV corresponding to a dose at which approximately 50% of wild-type (C57BL/6J) animals survive (LD50) [31]-[33] and measured time-dependent IL-10 secretion in plasma by ELISA (Figure 1 C). Results showed that IL-10 production began to increase in plasma as early as 6 h p.i. and reached approximately 18-fold at day 5 (120 h) compared to baseline (before infection, 0 h). These data raise the possibility that IL-10 may play a role in modulating immune responses during WNV infection.
###end p 11
###begin title 12
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 55 58 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
IL-10 expression is elevated in vitro and in vivo upon WNV infection.
###end title 12
###begin p 13
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 174 184 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 186 190 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actb</italic>
###xml 372 374 369 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 420 421 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 84 87 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 365 368 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 370 374 <span type="species:ncbi:11082">LD50</span>
Thioglycollate-elicited peritoneal macrophages from C57BL/6 mice were infected with WNV (MOI = 1) for 24 hours. (A), IL-10 mRNA was measured by Q-PCR and normalized to mouse beta-actin (Actb; unitless ratio+1 SEM). (B), ELISA results are shown for IL-10 protein (pg/ml) in the media. (C), Plasma was prepared at selected time points from C57BL/6 mice infected with WNV (LD50), and IL-10 (pg/ml) was measured by ELISA. * p<0.001.
###end p 13
###begin title 14
###xml 28 31 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
IL-10 signaling facilitates WNV infectivity
###end title 14
###begin p 15
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 97 99 97 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Town1">[33]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNVE</italic>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 412 422 412 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 A</bold>
###xml 412 422 412 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 A</bold></xref>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 597 605 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1169 1172 1169 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1164 1172 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1178 1181 1178 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1198 1199 1198 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1206 1216 1206 1216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 B</bold>
###xml 1206 1216 1206 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 B</bold></xref>
###xml 1298 1301 1298 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1293 1301 1293 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1506 1516 1506 1516 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 C</bold>
###xml 1506 1516 1506 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 C</bold></xref>
###xml 1521 1530 1521 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref>
###xml 1521 1530 1521 1530 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref></bold>
###xml 1671 1681 1671 1681 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 C</bold>
###xml 1671 1681 1671 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 C</bold></xref>
###xml 1686 1695 1686 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref>
###xml 1686 1695 1686 1695 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref></bold>
###xml 1734 1735 1734 1735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1809 1812 1809 1812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1804 1812 1804 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1819 1829 1819 1829 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 C</bold>
###xml 1819 1829 1819 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 C</bold></xref>
###xml 1929 1938 1929 1938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref>
###xml 1929 1938 1929 1938 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="ppat.1000610.s001">Figure S1</xref></bold>
###xml 1968 1971 1968 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1963 1971 1963 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 2047 2048 2047 2048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2055 2065 2055 2065 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 D</bold>
###xml 2055 2065 2055 2065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 D</bold></xref>
###xml 2153 2156 2153 2156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2148 2156 2148 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 2171 2174 2171 2174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 2289 2292 2289 2292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2284 2292 2284 2292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 2351 2361 2351 2361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 E</bold>
###xml 2351 2361 2351 2361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 E</bold></xref>
###xml 2448 2453 2448 2453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 41 44 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:11082">LD50</span>
###xml 108 111 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 159 163 <span type="species:ncbi:10090">Mice</span>
###xml 262 265 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 313 316 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 988 991 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1192 1196 <span type="species:ncbi:10090">mice</span>
###xml 1302 1306 <span type="species:ncbi:10090">mice</span>
###xml 1425 1428 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1486 1490 <span type="species:ncbi:10090">mice</span>
###xml 1784 1788 <span type="species:ncbi:10090">mice</span>
###xml 1813 1817 <span type="species:ncbi:10090">mice</span>
###xml 1972 1976 <span type="species:ncbi:10090">mice</span>
###xml 2033 2037 <span type="species:ncbi:10090">mice</span>
###xml 2157 2161 <span type="species:ncbi:10090">mice</span>
###xml 2167 2170 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 2293 2297 <span type="species:ncbi:10090">mice</span>
###xml 2430 2434 <span type="species:ncbi:10090">mice</span>
###xml 2483 2486 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 2542 2545 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
To evaluate a putative role for IL-10 in WNV pathogenesis, we challenged IL-10-/- mice with an LD50 dose of WNV via an i.p. route of administration [33],[34]. Mice were monitored twice daily for morbidity and mortality for three weeks. Q-PCR designed to measure WNV envelope gene (WNVE) revealed 2-3 fold reduced WNV RNA in blood samples from IL-10-/- mice compared to control mice at days 1 and 3 p.i. (p<0.05, Figure 2 A). Plaque formation assays were also performed to measure infectious viral particles in plasma samples. Consistent with Q-PCR data, plaque formation assay results showed that IL-10-/- mice had a similar magnitude of lower viral burden compared with control mice (data not shown). In selected experiments, we randomly sacrificed half the number of mice to collect spleen samples at day 3 and to collect brains at day 7, while the remaining mice were observed for survival analysis. Total RNA extracted from spleen and brain hemispheres was used for Q-PCR analysis of WNV burden. Contralateral brain hemispheres were fixed in 4% paraformaldehyde (PFA) for histological analysis. Markedly less viral RNA was present in the spleens and brains of IL-10-/- mice vs. wild-type mice (p<0.05, Figure 2 B). Confocal microscopy results were consistent with brain Q-PCR data in that IL-10-/- mice had little evidence of virus in the olfactory bulb (OB), cerebral cortex, striatum, cerebellum and brainstem, whereas WNV was readily detected in similar brain regions of control mice on day 7 p.i. (Figure 2 C and Figure S1). Co-immunostaining with the neuronal marker microtubule-associated protein 2 (MAP2) revealed that most of the infected cells were neurons (Figure 2 C and Figure S1). In addition, a higher number of CD45+ leukocytes infiltrated into brains of wild-type mice as compared to IL-10-/- mice (Figure 2 C). Similar results were observed when immunostaining for CD11b, a marker for macrophages/microglia (Figure S1). The survival ratio of IL-10-/- mice (70.0%) was significantly higher than that of wild-type mice (33.3%) (p<0.01, Figure 2 D). As virus inoculation routes may alter host immune responses, we also challenged IL-10-/- mice with WNV via footpad inoculation (100 pfu) route and performed survival analysis. Similar to intraperitoneal inoculation, IL-10-/- mice also had increased survival after footpad infection (Figure 2 E). Collectively, viral burden and survival analyses demonstrate that mice deficient in IL-10 have increased resistance to WNV infection, suggesting that IL-10 signaling facilitates WNV pathogenesis.
###end p 15
###begin title 16
###xml 28 31 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
IL-10 signaling facilitates WNV infection.
###end title 16
###begin p 17
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 74 76 74 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNVE</italic>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 194 202 194 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNVE</italic>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 709 712 709 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 897 900 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 892 900 892 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1015 1016 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1028 1029 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 67 70 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 72 76 <span type="species:ncbi:11082">LD50</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 432 435 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 751 754 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 854 857 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
Wild-type (WT, C57BL/6) or IL-10-/- mice were i.p. challenged with WNV (LD50). (A), Q-PCR was performed for WNVE in peripheral blood on days 1 (IL-10-/- mice, n = 14 and WT mice, n = 10) and 3 (IL-10-/- mice, n = 14 and WT mice, n = 9) p.i.. (B), Q-PCR was performed for WNVE in spleens on day 3 (n = 5/group) and brains on day 7 (IL-10-/- mice, n = 7 and WT mice, n = 9) p.i.. (C), Perfused brains were isolated on day 7 p.i., and WNV antigen (green signal), CD45 (leukocyte common antigen, red signal) and neurons (MAP2, blue signal) were detected by confocal microscopy (OB: Olfactory bulb). These images represent 9 mice per group in 3 independent experiments. (D), Kaplan-Meier survival analysis of IL-10-/- and WT mice after i.p. inoculation of WNV (n = 30/group). Data shown are pooled from 3 independent experiments. (E), Survival analysis after WNV inoculation by footpad injection (IL-10-/- mice, n = 8 and WT mice n = 10). Data (means+1 SEM) are pooled results from 2-3 similar independent experiments. *p<0.05 and **p<0.01, compared to control mice.
###end p 17
###begin p 18
###xml 662 672 662 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3 A</bold>
###xml 662 672 662 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g003"><bold>Figure 3 A</bold></xref>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 823 824 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 831 841 831 841 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3 B</bold>
###xml 846 847 846 847 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 831 847 831 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g003"><bold>Figure 3 B</bold> and <bold>C</bold></xref>
###xml 304 307 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 319 323 <span type="species:ncbi:10090">Mice</span>
###xml 398 401 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 493 496 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 647 650 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 910 913 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
We further tested this hypothesis by taking a pharmacological approach to interrupt IL-10 signaling. Specifically, we systemically administered anti-IL-10 receptor monoclonal antibody (aIL-10r mAb) to block IL-10 signaling. We injected aIL-10r mAb or isotype-matched control IgG (i.p.) on day 1 prior to WNV infection. Mice were challenged with 2,000 pfu (i.p.) or 100 pfu (footpad inoculation) of WNV. Blood samples were collected from the mice infected intraperitoneally on day 3 (p.i.) for WNV burden Q-PCR measurement. Q-PCR results showed a trend toward reduced viral burden in blood of mice treated with aIL-10r mAb prior to intraperitoneal WNV infection (Figure 3 A, p = 0.07). Survival analysis indicated that mice treated with aIL-10r mAb had increased survival compared to mice injected with isotype-matched IgG (p<0.05, Figure 3 B and C). These data further confirm that IL-10 signaling facilitates WNV infection and promotion of lethal encephalitis.
###end p 18
###begin title 19
###xml 63 66 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Prophylactic blockade of IL-10 signaling increases survival of WNV-infected mice.
###end title 19
###begin p 20
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 249 251 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 417 419 417 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 170 173 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 247 251 <span type="species:ncbi:11082">LD50</span>
###xml 415 419 <span type="species:ncbi:11082">LD50</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
A group of C57BL6 mice were i.p. administered anti-IL-10 receptor monoclonal antibody (aIL-10r mAb) or isotype-matched IgG control antibody one day before challenge with WNV. (A), Viral load was measured in blood on day 3 p.i. by Q-PCR (p = 0.07, LD50, i.p..); (B-C), Kaplan-Meier survival analysis showed significant differences between the aIL-10r mAb and isotype-matched IgG treated group. (B, i.p. inoculation [LD50], n = 17/group, data were pooled from 3 independent experiments; C, footpad inoculation [100 pfu], n = 10/group). *p<0.05, compared to control mice.
###end p 20
###begin title 21
###xml 60 63 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
IL-10 signaling suppresses antiviral cytokine production in WNV-challenged immune cells and mice
###end title 21
###begin p 22
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Town1">[33]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 324 332 324 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 688 700 677 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 A&#8211;D</bold>
###xml 688 700 677 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 A&#8211;D</bold></xref>
###xml 830 834 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Sitati1">[15]</xref>
###xml 835 839 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang5">[35]</xref>
###xml 1104 1107 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1099 1107 1084 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1189 1199 1174 1184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 E</bold>
###xml 1189 1199 1174 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 E</bold></xref>
###xml 1434 1438 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brien2">[36]</xref>
###xml 1439 1443 1420 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Purtha2">[37]</xref>
###xml 1443 1450 1424 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1573 1576 1550 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1568 1576 1545 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1583 1593 1560 1570 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 F</bold>
###xml 1598 1599 1575 1576 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1583 1599 1560 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 F</bold> and <bold>G</bold></xref>
###xml 1720 1723 1693 1696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1715 1723 1688 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1775 1777 1748 1750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1888 1891 1857 1860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1883 1891 1852 1860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1969 1979 1938 1948 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 H</bold>
###xml 1984 1985 1953 1954 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1969 1985 1938 1954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 H</bold> and <bold>I</bold></xref>
###xml 2081 2090 2050 2055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 2161 2170 2126 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 2188 2191 2149 2152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2183 2191 2144 2152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 2337 2347 2298 2308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 J</bold>
###xml 2337 2347 2298 2308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 J</bold></xref>
###xml 63 66 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 111 114 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 208 211 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 419 422 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 560 563 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 719 722 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 749 752 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 924 927 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 978 981 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1183 1187 <span type="species:ncbi:10090">mice</span>
###xml 1397 1400 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1577 1581 <span type="species:ncbi:10090">mice</span>
###xml 1746 1750 <span type="species:ncbi:10090">mice</span>
###xml 1758 1761 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1773 1777 <span type="species:ncbi:11082">LD50</span>
###xml 1892 1896 <span type="species:ncbi:10090">mice</span>
###xml 1923 1927 <span type="species:ncbi:10090">mice</span>
###xml 2192 2196 <span type="species:ncbi:10090">mice</span>
###xml 2247 2251 <span type="species:ncbi:10090">mice</span>
###xml 2561 2564 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
We have previously shown that macrophages can be infected with WNV, and are likely an important target cell in WNV pathogenesis [33],[34]. To dissect the mechanisms underlying how IL-10 signaling facilitates WNV infection, we measured cytokine expression in macrophages from IL-10-/- and wild-type mice upon virus infection in vitro. We infected thioglycollate-elicited macrophages obtained from peritoneal lavage with WNV, and quantified cytokines by ELISA or Q-PCR at selected time points. Consistent with a stronger anti-viral response, results showed that WNV-infected macrophages from IL-10-/- mice produced more TNF-alpha, IFN-alpha, IFN-beta and IL-12/23 p40 than wild-type cells (Figure 4 A-D). The spleen is a WNV target organ, and splenic WNV infection is thought to be involved in host immune defense against infection [15],[35]. We therefore assessed cytokine production in splenic cells isolated from naive and WNV-infected mice. We infected naive splenocytes with WNV (MOI = 0.5) and measured production of IL-12/23 p40 and IFN-gamma by ELISA at selected time points. Splenocytes from IL-10-/- mice produced elevated IL-12/23 p40 compared to splenocytes from wild-type mice (Figure 4 E), while IFN-gamma production was not detected by ELISA in either group. We also quantified cytokine production from splenocytes isolated on day 3 p.i.. Specifically, we stimulated splenocytes with WNV MHC class I epitope peptide NS4b [36],[37]ex vivo for 24 or 48 h. ELISA results showed that TNF-alpha and IL-12/23 p40 were significantly elevated in splenocytes from IL-10-/- mice (Figure 4 F and G), while IFN-gamma production was undetectable. In addition, we evaluated cytokine secretion in peripheral blood of IL-10-/- compared to wild-type mice during WNV infection (LD50, i.p.) by ELISA or Q-PCR. ELISA results showed that IL-12/23 p40 and TNF-alpha production in plasma from IL-10-/- mice was higher than wild-type mice plasma samples on day 2 after infection (Figure 4 H and I). Because IFN protein production in plasma was below the detection level of ELISA, we measured IFN-gamma mRNA levels in blood by Q-PCR. The Q-PCR data show that expression of IFN-gamma in blood of IL-10-/- mice trended toward significantly lower than wild-type mice in all the selected time points, and reached statistical significance on day 3 p.i. (Figure 4 J). Collectively, these data suggest that genetic blockade of IL-10 signaling results in a significant elevation of type I IFN and proinflammatory cytokines in macrophages, splenic cells and peripheral blood during WNV infection.
###end p 22
###begin title 23
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Immune cells and mice deficient in IL-10 produce more antiviral cytokines.
###end title 23
###begin p 24
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 281 293 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12/23 p40</italic>
###xml 353 363 342 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 499 502 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 494 502 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 664 667 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 659 667 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 696 698 682 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 747 748 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 881 884 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 876 884 854 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 923 925 901 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1056 1065 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 1067 1071 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifng</italic>
###xml 1214 1216 1182 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*p</italic>
###xml 1223 1226 1191 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**p</italic>
###xml 1239 1240 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 106 109 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 533 536 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 646 649 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:11082">LD50</span>
###xml 725 728 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 916 919 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 921 925 <span type="species:ncbi:11082">LD50</span>
Thioglycollate elicited peritoneal macrophages from IL-10-/- and wild-type (WT) mice were challenged with WNV (MOI = 1) or PBS (mock infection) for 24 hours. (A-C), TNF-alpha, IFN-alpha and IFN-beta were measured in media by ELISA. (D), Total RNA from macrophages was analyzed for IL-12/23 p40 mRNA expression by Q-PCR. The data are normalized to mouse beta-actin mRNA and are expressed as the relative fold increase over normalized RNA from mock controls. (E), Splenocytes isolated from naive IL-10-/-and WT mice were infected with WNV (MOI = 0.5), and IL-12/23 p40 production was measured in media by ELISA. (F and G) Splenocytes isolated from WNV-infected IL-10-/- or WT mice on day 3 p.i. (LD50, i.p.) were stimulated by WNV NS4b peptide (1x106 cells, 1.0 microg/ml) for 24 or 48 hours. TNF-alpha (F) and IL-12/23 p40 (G) were measured in media by ELISA. (H and I) WT and IL-10-/- mice were i.p. challenged with WNV (LD50) and bled on day 1, day 2 and 3 p.i., and IL-12/23 p40 (H) and TNF-alpha (I) were measured in plasma by ELISA. (J), Expression of IFN-gamma (Ifng) was measured in peripheral blood by Q-PCR. These data are representative of two independent experiments, with animal numbers >/=4 per group. *p<0.05, **p<0.01 and ***p<0.001.
###end p 24
###begin p 25
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 232 240 232 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 260 268 260 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 379 367 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup> vs.</italic>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 428 436 428 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 474 484 474 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5 A</bold>
###xml 489 490 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 474 490 474 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g005"><bold>Figure 5 A</bold> and <bold>B</bold></xref>
###xml 579 582 579 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 574 582 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 741 751 734 744 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5 C</bold>
###xml 741 751 734 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g005"><bold>Figure 5 C</bold></xref>
###xml 872 875 865 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 867 875 860 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1132 1135 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1127 1135 1120 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1212 1220 1205 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1222 1232 1215 1225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5 D</bold>
###xml 1222 1232 1215 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g005"><bold>Figure 5 D</bold></xref>
###xml 1360 1368 1353 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1390 1393 1383 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1385 1393 1378 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1407 1415 1400 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1461 1468 1454 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1536 1539 1529 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1531 1539 1524 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1563 1570 1556 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 1623 1624 1616 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1664 1667 1657 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1659 1667 1652 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1743 1744 1736 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1751 1761 1744 1754 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5 E</bold>
###xml 1751 1761 1744 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g005"><bold>Figure 5 E</bold></xref>
###xml 1827 1830 1820 1823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1822 1830 1815 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 121 124 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 196 199 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 459 462 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 726 729 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 831 834 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 979 982 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1027 1033 <span type="species:ncbi:10090">murine</span>
###xml 1034 1060 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 1062 1066 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1198 1201 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1372 1375 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1540 1544 <span type="species:ncbi:10090">mice</span>
###xml 1548 1552 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1668 1672 <span type="species:ncbi:10090">mice</span>
###xml 1737 1741 <span type="species:ncbi:10090">mice</span>
###xml 1831 1835 <span type="species:ncbi:10090">mice</span>
Increased type I IFN and innate immune proinflammatory cytokines might be expected to contribute to efficient control of WNV infection after IL-10 signaling blockade. To assess this, we evaluated WNV replication in macrophages from IL-10-/- and wild-type mice in vitro by Q-PCR and plaque formation assay. Both assays indicated lower viral burden in macrophages from IL-10-/- vs. wild-type mice, showing increased resistance of IL-10-/- macrophages to direct WNV infection (Figure 5 A and B). To further assess whether type I IFN plays an antiviral role in macrophages from IL-10-/- mice, we incubated macrophages with anti-IFN-alpha/beta receptor neutralizing mAb and measured viral replication by Q-PCR after infection with WNV (MOI = 1) (Figure 5 C). Q-PCR results showed that neutralizing antibody treatment partially restored WNV replication in macrophages from IL-10-/- mice. We next measured type I IFN activity in the media of naive splenic cells that were infected with WNV (MOI = 0.5) using a virus protection assay (murine encephalomyocarditis virus [EMCV] bioassay). These results suggested that splenic cells from IL-10-/- mice secrete more type I IFN compared to wild-type mice after WNV infection in vitro (Figure 5 D). The results of the antibody treatment and bioassay experiments indicated that type I IFN production limits viral replication in vitro in WNV-infected IL-10-/- immune cells in vitro. To determine if something similar may occur in vivo, we measured type I IFN activity in plasma from wild-type and IL-10-/- mice by EMCV bioassay. Results showed similar type I IFN activity at days 1 and 5 (p>0.1), while at day 3, plasma from IL-10-/- mice had significantly reduced activity compared with plasma from WT mice (p<0.01, Figure 5 E), which may due to a lower virus burden in the periphery of IL-10-/- mice.
###end p 25
###begin title 26
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 44 47 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Type I IFN is associated with inhibition of WNV infectivity in vitro.
###end title 26
###begin p 27
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNVE</italic>
###xml 289 292 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 483 487 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNVE</italic>
###xml 577 580 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 572 580 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 700 703 689 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 695 703 684 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 737 739 726 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 798 800 787 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*p</italic>
###xml 810 813 799 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**p</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 119 122 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 364 370 <span type="species:ncbi:9986">rabbit</span>
###xml 379 385 <span type="species:ncbi:9986">rabbit</span>
###xml 449 452 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 605 608 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 730 733 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 735 739 <span type="species:ncbi:11082">LD50</span>
(A-B) One million thioglycollate-elicited peritoneal macrophages isolated from IL-10-/- and WT mice were infected with WNV (MOI = 1) for 24 hours. (A), WNVE was measured in macrophages by Q-PCR and (B) viral load was measured in media by plaque formation assay. (C), Macrophages from IL-10-/- mice were treated with or without (mock) 20 microg/ml of either normal rabbit IgGs or rabbit anti-IFNalpha/betaR1 IgGs (R&D Biosystems) for 2 h followed by WNV infection (MOI = 1) for 24 h. WNVE was measured in macrophages by Q-PCR. (D), Splenic cells isolated from naive WT and IL-10-/- mice were infected with WNV (MOI = 0.5). Type I IFN level in the medium was measured by IFN bioassay. (E), WT and IL-10-/- mice were inoculated with WNV (LD50, i.p.) and type I IFN level was measured by IFN bioassay. *p<0.05 and **p<0.01.
###end p 27
###begin p 28
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Sitati1">[15]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Shrestha2">[17]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Shrestha4">[21]</xref>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 171 172 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 219 222 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 223 226 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Maris1">[9]</xref>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 264 265 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 335 343 335 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 637 638 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 647 648 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 656 657 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 666 667 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 709 712 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 704 712 692 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 719 731 707 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6 A&#8211;C</bold>
###xml 719 731 707 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g006"><bold>Figure 6 A&#8211;C</bold></xref>
###xml 795 798 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 790 798 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 864 874 848 858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 J</bold>
###xml 864 874 848 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 J</bold></xref>
###xml 980 983 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 975 983 955 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1040 1043 1020 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1035 1043 1015 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1269 1270 1245 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1278 1279 1254 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1304 1307 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1299 1307 1275 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1368 1378 1340 1350 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6 D</bold>
###xml 1368 1378 1340 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g006"><bold>Figure 6 D</bold></xref>
###xml 1456 1459 1428 1431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1451 1459 1423 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1553 1556 1525 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1548 1556 1520 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1605 1606 1573 1574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1614 1615 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1672 1675 1640 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1667 1675 1635 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 60 63 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 312 315 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 958 961 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1103 1107 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
###xml 1362 1366 <span type="species:ncbi:10090">mice</span>
###xml 1460 1464 <span type="species:ncbi:10090">mice</span>
###xml 1513 1516 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1676 1680 <span type="species:ncbi:10090">mice</span>
CD4+ and CD8+ T cells play an important role in recovery of WNV infection in the mouse model [15], [17]-[21]. In addition, host IL-10 expression may result in CD4+ and CD8+ T cell exhaustion in chronic viral infections [7]-[9]. We investigated whether CD4+ and CD8+ T cells contribute to increased resistance to WNV infection noted in IL-10-/- mice. On day 7 p.i., splenocytes were isolated from IL-10-/- and wild-type control mice and stimulated with PMA or peptide NS4b for 6 h. Total splenic cells were stained for CD4 and CD8 surface markers and for intracellular IFN-gamma. Flow cytometry analysis showed that the frequencies of CD8+IFN-gamma+ and CD4+IFN-gamma+ cells were significantly reduced in IL-10-/- mice (Figure 6 A-C). These results are consistent with IFN-gamma in blood of IL-10-/- mice, which trended toward reduced compared with wild-type mice (Figure 4 J). These data suggest that IFN-gamma does not play a dominant role in mitigation of WNV infection in IL-10-/- mice. To exclude the possibility that T cells from IL-10-/- mice may not be as responsive as those that from wild-type mice, we stimulated spenocytes from naive mice with PMA for 6 h and stained for CD4 and CD8 surface markers and for intracellular IFN-gamma. The results show that CD4+ and CD8+ T cells from naive IL-10-/- mice produce more INF-gamma than those from wild-type mice (Figure 6 D), suggesting that response to PMA stimulation is intact in T cells from IL-10-/- mice. Collectively, these data suggest that elevated WNV-induced antiviral cytokines in IL-10-/- immune cells but not IFN-gamma production in CD4+ and CD8+ T cells likely serve to limit viral replication in IL-10-/- mice.
###end p 28
###begin title 29
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
CD4+ and CD8+ T cells deficient in IL-10 produce less IFN-gamma.
###end title 29
###begin p 30
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 6 14 6 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 72 74 72 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 245 246 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 392 393 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 550 553 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 545 553 537 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 653 654 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 662 663 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 698 699 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 709 712 697 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**p</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 65 68 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 70 74 <span type="species:ncbi:11082">LD50</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 165 168 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 298 301 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
(A-C) IL-10-/- and wild-type (WT) mice were i.p. challenged with WNV (LD50). On day 7, mice were euthanized and splenocytes were isolated and stimulated with PMA or WNV NS4b peptide for 6 hours. Flow cytometry analysis of IFN-gamma-producing CD8+ T cells after stimulation with (A) PMA or (B) with WNV NS4b peptide was then carried out. (C), Flow cytometry analysis of IFN-gamma producing CD4+ T cells after stimulation with PMA is shown. These data represent two independent experiments (n = 4/group). (D), Splenocytes were isolated from naive IL-10-/- and WT mice and stimulated with PMA for 6 hours. Flow cytometry analysis of IFN-gamma-producing CD4+ and CD8+ T cells is shown (n = 3/group). * p<0.05 and **p<0.01.
###end p 30
###begin title 31
###xml 50 53 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
IL-10 neutralizing mAb is protective after lethal WNV infection
###end title 31
###begin p 32
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 296 303 296 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">after</italic>
###xml 448 450 448 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 771 772 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 779 787 779 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7</bold>
###xml 779 787 779 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g007"><bold>Figure 7</bold></xref>
###xml 98 101 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 188 191 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 314 317 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 360 363 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 441 444 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 446 450 <span type="species:ncbi:11082">LD50</span>
###xml 712 715 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
As blockade of IL-10 signaling via genetic means leads to enhanced anti-viral immunity mitigating WNV infection, we wanted to assess the effect of pharmacological IL-10 blockade on lethal WNV encephalitis. We used a monoclonal antibody directed against IL-10 (anti-IL-10 mAb) to neutralize IL-10 in vivo following WNV infection. Because a treatment course for WNV disease would begin after exposure to the virus, we first infected mice with WNV (LD50, i.p.) and followed by treatment with two daily i.p. doses of anti-IL-10 mAb or isotype-matched IgG control antibody. Antibodies were injected starting on day 2 or day 4 p.i. Survival curves indicate that anti-IL-10 antibody significantly increases survival of WNV-infected mice when administered as late as day 2 p.i. (p<0.05, Figure 7). Yet, this effect is abolished when the neutralizing antibody is administrated on day 4 p.i., as survival rates are similar between the two groups (data not shown).
###end p 32
###begin title 33
###xml 60 63 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Pharmacologic neutralization of IL-10 increases survival of WNV-infected mice.
###end title 33
###begin p 34
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 204 205 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 282 283 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 46 49 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 51 55 <span type="species:ncbi:11082">LD50</span>
###xml 58 62 <span type="species:ncbi:10090">Mice</span>
Wild-type (WT) mice were i.p. challenged with WNV (LD50). Mice received two i.p. injections of anti-IL-10 monoclonal antibody (aIL-10 mAb, 200 microg/dose) or isotype control IgG on day 2 and day 3 p.i. (p<0.05, n = 15/group). Data were pooled from three independent experiments. * p<0.05.
###end p 34
###begin title 35
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 61 64 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
CD4+ T cells produce copious amounts of IL-10 in vivo during WNV infection
###end title 35
###begin p 36
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Jankovic1">[38]</xref>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Kamanaka1">[40]</xref>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tiger</italic>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Kamanaka1">[40]</xref>
###xml 665 672 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tiger</italic>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 927 928 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 944 945 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 958 959 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 972 973 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1021 1031 1021 1031 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8 A</bold>
###xml 1021 1031 1021 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g008"><bold>Figure 8 A</bold></xref>
###xml 1090 1091 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1104 1105 1104 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1108 1109 1108 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1150 1160 1150 1160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8 A</bold>
###xml 1150 1160 1150 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g008"><bold>Figure 8 A</bold></xref>
###xml 1205 1206 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1209 1210 1209 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1303 1313 1303 1313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 C</bold>
###xml 1303 1313 1303 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g001"><bold>Figure 1 C</bold></xref>
###xml 1343 1344 1343 1344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 303 306 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 354 359 <span type="species:ncbi:9694">tiger</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 744 749 <span type="species:ncbi:9694">tiger</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 833 836 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1276 1280 <span type="species:ncbi:10090">mice</span>
###xml 1288 1291 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1393 1396 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1410 1414 <span type="species:ncbi:10090">mice</span>
IL-10 is provided by various cellular sources in different disease models [38]-[40]. A better understanding of the cellular sources of IL-10 and mechanisms of induction is required to define an effective immunotherapeutic strategy aimed at IL-10. To identify the cellular source of IL-10 in vivo during WNV infection, we used IL-10-GFP reporter knock-in tiger mice, in which an internal ribosome entry site GFP element was inserted into the 3' region of the IL-10 gene. During characterization of these mice, GFP and IL-10 expression were found to be closely correlated in all cell populations tested [40], thus allowing the identification of IL-10-producing cells ex vivo without subsequent manipulation. We examined splenocytes isolated from tiger mice for expression of GFP and various cell-surface markers on selected days after WNV infection. No significant GFP production from macrophages (CD11b+), dendritic cells (CD11c+), B cells (CD19+), or non-CD4+ T cells (CD3+CD4-) was observed at any selected time points (Figure 8 A). However, a significant amount of GFP was produced by CD4+ T cells (CD3+CD4+), which peaked on day 5 post infection (Figure 8 A). This time course of IL-10 induction in CD3+CD4+ cells is consistent with IL-10 production in plasma of wild-type mice during WNV infection (Figure 1 C). These data suggest that CD4+ T cells secrete copious amounts of IL-10 during WNV infection in mice.
###end p 36
###begin title 37
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 61 64 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
CD4+ T cells produce copious amounts of IL-10 in vivo during WNV infection.
###end title 37
###begin p 38
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tiger</italic>
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tiger</italic>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 405 406 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 625 628 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 621 628 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 661 662 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 693 696 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 696 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 707 708 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 779 781 777 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 885 886 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 897 900 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 893 900 891 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 928 929 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 23 <span type="species:ncbi:9694">tiger</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 83 86 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 88 92 <span type="species:ncbi:11082">LD50</span>
###xml 121 124 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 134 139 <span type="species:ncbi:9694">tiger</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
###xml 762 765 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 777 781 <span type="species:ncbi:11082">LD50</span>
###xml 790 794 <span type="species:ncbi:10090">Mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
GFP gene knock-in tiger and wild-type (WT, C57BL/6) mice were i.p. challenged with WNV (LD50). Splenocytes isolated from WNV-infected tiger mice at selected time points p.i. were stained for surface markers (day 0, uninfected splenocytes). GFP was used as a surrogate for IL-10 expression, and analyzed by flow cytometry. (A), Percentages of GFP positive cells are shown within CD11b+ (macrophages), CD11c+ (dendritic cells), CD19+ (B cells), non-CD4+ (CD3+CD4-) T cells or CD4+ (CD3+CD4+) T cells populations. Dot-plot figures are representative of at least two independent experiments (n>/=2 for each experiment). (B), RAG1-/- mice were reconstituted with CD4+ T cells from naive WT or IL-10-/- mice (1x107 cells/mouse) or with PBS as control one day prior to WNV challenge (LD50, i.p.). Mice were bled at selected time points and IL-10 production was measured in plasma by ELISA (**p<0.01, RAG1-/- mice reconstituted with CD4+ T cells from WT mice were compared to control mice, n>/=3/group).
###end p 38
###begin p 39
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 208 210 208 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 315 322 315 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 335 342 335 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 509 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 501 509 501 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 639 629 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8 B</bold>
###xml 629 639 629 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g008"><bold>Figure 8 B</bold></xref>
###xml 711 714 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 707 714 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 749 750 749 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 764 772 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 803 813 803 813 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8 B</bold>
###xml 803 813 803 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g008"><bold>Figure 8 B</bold></xref>
###xml 852 853 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 960 967 960 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1007 1008 1007 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 191 194 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 206 210 <span type="species:ncbi:11082">LD50</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 606 609 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 946 949 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1080 1086 <span type="species:ncbi:10090">murine</span>
###xml 1087 1090 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
To further confirm this conclusion, we reconstituted RAG1-/- mice that lack T and B cells with naive CD4+ T cells from wild-type or IL-10-/- mice or PBS (cell-free control) on day 1 prior to WNV infection (LD50, i.p.). We subsequently measured IL-10 levels in plasma by ELISA at serial time points after infection. Results showed that RAG1-/- mice reconstituted with CD4+ T cells from wild-type mice produced significantly higher amounts of IL-10 than mice reconstituted with PBS or CD4+ T cells from IL-10-/- mice, providing definitive evidence that CD4+ T cells produce a significant amount IL-10 during WNV infection in mice (Figure 8 B). It is worth noting that IL-10 was also detected in plasma of the RAG1-/- mice reconstituted with PBS or CD4+ T cells from IL-10-/- mice, albeit at lower levels (Figure 8 B), suggesting that cells other than CD4+ T cells (such as macrophages) play a certain but subdominant role in secreting IL-10 during WNV infection in vivo. Therefore, these data confirm that CD4+ T cells produce a significant amount, but not all, of the IL-10 in the murine WNV infection paradigm.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 304 307 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Moore1">[3]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Pestka1">[41]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Couper2">[42]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brooks1">[8]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Accapezzato1">[43]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Woitas1">[44]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ameglio1">[45]</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Clerici1">[46]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Rico1">[47]</xref>
###xml 720 723 720 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 724 727 724 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brooks1">[8]</xref>
###xml 892 895 892 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 896 899 896 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brooks1">[8]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Brooks2">[48]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Trabattoni1">[49]</xref>
###xml 36 39 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 499 516 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 528 556 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 571 588 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 694 698 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 776 780 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1008 1012 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1013 1018 <span type="species:ncbi:10090">mouse</span>
###xml 1095 1098 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Studies on host immune responses to WNV infection will not only result in a better understanding of viral pathogenesis, but may also lead to novel immunotherapeutic strategies against viral infection. IL-10 plays an immunosuppressive role through interaction between antigen presenting cells and T cells [3],[41],[42]. IL-10 was also found to induce T cell exhaustion during chronic viral infections [7],[8]. Systemic IL-10 production is increased in various human chronic viral infections, such as hepatitis C virus [43],[44], human immunodeficiency virus [45],[46] and hepatitis B virus [47]. Studies demonstrate that the IL-10/IL-10R pathway plays a key role in the establishment of chronic LCMV persistent infection [7],[8]. Blockade of IL-10 signaling converts a chronic LCMV infection into a rapidly controlled acute viral infection and prevents functional exhaustion of memory T cells [7],[8]. Further, a recent study suggests that IL-10 blockade facilitates DNA-vaccine induced T cell response in an LCMV mouse model [48]. Interestingly, IL-10 production correlates directly with plasma HIV viral load and inversely with CD4 cell counts [49].
###end p 41
###begin p 42
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Dai1">[31]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang6">[50]</xref>
###xml 828 831 828 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 823 831 823 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1141 1144 1141 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1132 1144 1132 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs. IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1269 1274 1269 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 103 109 <span type="species:ncbi:10090">murine</span>
###xml 124 127 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 238 241 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 275 278 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 477 480 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 518 521 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 729 732 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 838 841 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1113 1116 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1295 1298 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In this study, we observed that IL-10 expression was dramatically up-regulated in vitro and in vivo in murine plasma during WNV infection, raising the possibility that IL-10 plays a significant role in modulating host immune responses to WNV infection. Through evaluation of WNV infection in IL-10-/- mice and in wild-type mice that were administered anti-IL-10r mAb or IL-10 neutralizing antibody to temporally block IL-10 signaling, we found that IL-10 signaling facilitates WNV infectivity and lethal encephalitis. WNV is a neuroinvasive virus that develops low viremia in mice by replicating in peripheral organs including spleen, and then infecting neurons causing meningitis and lethal encephalitis in mice [31],[34],[50]. WNV is most often cleared from blood and peripheral organs between one and two weeks p.i.. In IL-10-/- mice, WNV load was significantly reduced in the blood and spleen, suggesting that viral replication was efficiently inhibited in the periphery. Consequently, the likelihood that the virus would infect neurons was greatly reduced. We also performed direct intracranial injection of WNV into wild-type vs. IL-10-/- mice and evaluated survival. We did not detect a difference using this route of infection (data not shown), suggesting that IL-10 deficiency promotes WNV clearance at the level of the periphery as opposed to the brain.
###end p 42
###begin p 43
###xml 173 176 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Moore1">[3]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Pestka1">[41]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Couper2">[42]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Samuel1">[11]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Tobler1">[14]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Yang1">[51]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-King1">[53]</xref>
###xml 417 420 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 412 420 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 968 971 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 963 971 963 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1177 1180 1170 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1172 1180 1165 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1318 1321 1311 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1313 1321 1306 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1335 1343 1328 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1408 1411 1401 1404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1403 1411 1396 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1491 1501 1484 1494 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5 E</bold>
###xml 1491 1501 1484 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g005"><bold>Figure 5 E</bold></xref>
###xml 1612 1622 1605 1615 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 A</bold>
###xml 1612 1622 1605 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 A</bold></xref>
###xml 1664 1667 1657 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1659 1667 1652 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1888 1898 1881 1891 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 C</bold>
###xml 1888 1898 1881 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g001"><bold>Figure 1 C</bold></xref>
###xml 70 73 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 289 292 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 450 455 <span type="species:ncbi:10090">mouse</span>
###xml 545 548 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 602 605 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 944 947 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1104 1108 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
###xml 1216 1219 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
###xml 1476 1480 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1606 1610 <span type="species:ncbi:10090">mice</span>
We next dissected the mechanisms by which IL-10 signaling facilitates WNV infectivity. IL-10 suppresses Th1 responses that are essential to restrict intracellular pathogens [3],[41],[42], and previous studies suggested that IFN and proinflammatory cytokine responses are important in anti-WNV immunity [11], [14], [51]-[53]. Consistent with this notion, we found that these antiviral cytokines were increased in IL-10-/- macrophages, splenocytes and mouse blood. Macrophages not only produce type I IFN, proinflammatory cytokines and IL-10 upon WNV infection, but they can also be directly infected by WNV. Interestingly, we noted MOI-dependent increases in IL-10 production from wild-type macrophages (MOIs from 0.01 to 1.0), supporting the notion that macrophage IL-10 production is directly correlated with viral abundance. We confirmed that increased abundance of type I IFN and proinflammatory cytokines were associated with inhibition of WNV replication in IL-10-/- macrophages, and this inhibitory effect was significantly reversed by antagonistic IFN-alpha/beta receptor antibodies. In addition, EMCV bioassay results demonstrated that splenic cells isolated from IL-10-/- mice produced more type I IFN upon WNV infection. These data are in line with the notion that type I IFN plays an antiviral role in IL-10-/- immune cells in vitro. However, a lower type I IFN activity level in plasma from IL-10-/- mice compared with wild-type mice at day 3 p.i. was detected by EMCV bioassay (Figure 5 E). This may be resolved by the following reasoning. It is possible that higher viral burden in wild-type mice (Figure 2 A) stimulates wild-type compared with IL-10-/- immune cells to produce more type I IFN. This response may be especially evident in the early phase of infection, because at this stage production of regulatory cytokines (such as IL-10) occurs at relatively low levels (Figure 1 C).
###end p 43
###begin p 44
###xml 88 97 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 190 194 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Couper2">[42]</xref>
###xml 195 199 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wagner1">[54]</xref>
###xml 200 204 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Dai2">[55]</xref>
###xml 493 497 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-DAndrea1">[56]</xref>
###xml 498 502 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Rennick1">[59]</xref>
###xml 572 575 556 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 567 575 551 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 779 782 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Ejrnaes1">[7]</xref>
###xml 783 786 763 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Maris1">[9]</xref>
###xml 893 896 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 888 896 864 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 917 924 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 977 978 949 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 986 987 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1025 1028 997 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1020 1028 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1053 1065 1025 1037 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6 A&#8211;C</bold>
###xml 1053 1065 1025 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g006"><bold>Figure 6 A&#8211;C</bold></xref>
###xml 1122 1125 1090 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1117 1125 1085 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1180 1190 1148 1158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4 J</bold>
###xml 1180 1190 1148 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g004"><bold>Figure 4 J</bold></xref>
###xml 1201 1204 1169 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1196 1204 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1278 1288 1246 1256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2 A</bold>
###xml 1293 1294 1261 1262 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1278 1294 1246 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g002"><bold>Figure 2 A</bold> and <bold>B</bold></xref>
###xml 1389 1392 1353 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1384 1392 1348 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 511 514 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 604 607 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 871 874 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
###xml 1354 1357 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
Studies on infections of bacteria, protozoa and some viruses suggest that expression of IFN-gamma is up-regulated and participates in controlling infection in the absence of IL-10 signaling [42],[54],[55]. The ability of IL-10 to down-regulate IFN-gamma production is a consequence of its ability to inhibit accessory cell function, including production of cytokines (such as TNF-alpha and IL-12) and expression of costimulatory molecules that are necessary for optimal stimulation of T cells [56]-[59]. In our WNV model, we found that IFN-gamma was not inducible in IL-10-/- immune cells or mice during WNV infection. Studies in chronic infection models have shown that host IL-10 production results in exhaustion of virus-specific T cells and reduction of IFN-gamma expression [7]-[9]. We next examined IFN-gamma expression on T cells by flow cytometry analysis during WNV infection in IL-10-/- mice on day 7 p.i.. Results showed that the frequency of IFN-gamma-producing CD4+ and CD8+ T cells was remarkably lower in IL-10-/- than in wild-type mice (Figure 6 A-C). Consistently, IFN-gamma expression in blood from IL-10-/- mice trended toward reduced from day 1 to day 3 p.i. (Figure 4 J). In IL-10-/- mice, viral replication was significantly inhibited following infection (Figure 2 A and B), indicating that IFN-gamma is dispensable for controlling WNV infection in the model of IL-10-/- mice, particularly during the early stage of infection.
###end p 44
###begin p 45
###xml 84 88 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Shrestha5">[60]</xref>
###xml 157 160 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 152 160 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 320 324 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 523 526 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 684 688 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 811 815 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Daffis2">[32]</xref>
###xml 817 821 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Wang4">[34]</xref>
###xml 823 827 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Verma1">[61]</xref>
###xml 828 832 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Kobiler1">[63]</xref>
###xml 999 1002 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 994 1002 974 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1181 1184 1161 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1176 1184 1156 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 56 59 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 172 175 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 306 309 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 440 443 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 493 496 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 566 569 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 797 800 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 899 902 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1003 1006 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1068 1071 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1214 1217 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In a previous study, TNF-alpha was shown to participate WNV control in mouse models [60], and we observed that TNF-alpha expression was up-regulated in IL-10-/- mice after WNV infection. It is worth noting that TNF-alpha has also been shown to increase permeability of the blood-brain-barrier (BBB) during WNV infection [34]. There are a number of variables, including the roles of TNF-alpha in anti-viral immunity independent of a role in WNV BBB permeabilization, the relative importance of WNV BBB permeability at early vs. later stages of infection, and whether WNV entry into the brain via the BBB (as opposed to indirect brain entry via brain penetration of infected leukocytes [34]) is a critical pathway for brain infection and subsequent encephalitis, that are dynamically at play during WNV infection [32], [34], [61]-[63]. These variables make direct determination of the contribution of WNV-induced TNF-alpha expression in BBB permeability complex and difficult to determine in our IL-10-/- WNV infection system. We did not examine BBB permeability during WNV infection in the present study because viral replication is significantly inhibited in the periphery of IL-10-/- mice and the likelihood that WNV would infect neurons is therefore correspondingly low. Thus, it does not appear to be necessary to invoke a BBB permeability hypothesis to explain our current results.
###end p 45
###begin p 46
###xml 352 357 <span type="species:ncbi:9606">human</span>
###xml 370 373 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 622 625 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 775 778 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 915 918 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1493 1496 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Upon viral infection, host innate immune sensors, including Toll-like receptors, double-stranded RNA-activated protein kinase (PKR), retinoic-acid-inducible protein I (RIG-I) and melanoma-differentiation-associated gene 5 (MDA-5), can be activated to produce type I IFNs and cytokines that limit viral replication and dissemination. In the majority of human infections, WNV is controlled and cleared by anti-viral immune responses before the virus invades the central nervous system. However, for the elderly and immunocompromised patients, for whom innate immune responses are too weak or impaired to efficiently control WNV infection, life-threatening neuroinvasive disease may result. In the present study, we found that IL-10 inhibits host innate immune responses during WNV infection. Importantly, blockade of IL-10 signaling through administration of neutralizing IL-10 antibody was able to partially protect WNV-infected mice from death, suggesting a promising immunotherapeutic strategy. The therapeutic effect of neutralizing IL-10 antibody was significant when administered as late as day 2 p.i., and it is possible that its efficacy may be extended by using higher doses of IL-10 signaling blocking antibodies or small molecule compounds that inhibit the IL-10 signaling pathway. Blocking IL-10 signaling to stimulate host immune responses rather than directly targeting viral genes has the added advantage that it is less likely to lead to the emergence of mutant virus. This anti-WNV strategy may also be combined with other currently available supportive measures, such as IFN therapy, in order to reap better clinical outcomes.
###end p 46
###begin p 47
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 406 413 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 415 425 415 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 A</bold>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 415 431 415 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000610-g001"><bold>Figure 1 A</bold> and <bold>B</bold></xref>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Jankovic1">[38]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Couper1">[39]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Couper2">[42]</xref>
###xml 748 749 748 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 817 824 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1387 1390 1387 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1382 1390 1382 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 1437 1440 1437 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1432 1440 1432 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 58 61 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 317 320 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 402 405 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 803 806 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1391 1395 <span type="species:ncbi:10090">mice</span>
###xml 1403 1406 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
###xml 1608 1611 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1639 1646 <span type="species:ncbi:9606">patient</span>
###xml 1843 1846 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Identification of a major cellular source of IL-10 during WNV infection in mice would, in principle, provide a more accurate target for modulation of IL-10 signaling as a therapeutic strategy. We found that CD4+ T cells produce a significant amount of IL-10 and may be a major cellular source of IL-10 in vivo during WNV infection. Our data also indicate that macrophages produce IL-10 when exposed to WNV ex vivo (Figure 1 A and B), which is consistent with in vivo results showing that CD11b+ macrophages produce low levels of IL-10. It is becoming evident that naturally occurring or adaptive CD4+ regulatory T cells produce copious amounts of IL-10 in different disease models [38],[39],[42]. Further studies are warranted to identify which CD4+ T cell subset is a major IL-10 producing cell during WNV infection in vivo. However, it should be noted that such a therapeutic strategy would need to be carefully titrated, as IL-10 signaling can also be beneficial by limiting extensive immunopathological damage resulting from uncontrolled Th1 or lymphokine-responsive T effector cell responses. Thus, while modulation of IL-10 signaling may be a means to enhance anti-pathogen immunity or limit immunopathology, this must be approached with caution to avoid tipping the balance too far in either direction. It is worth noting that we did not observe any overt immunopathology in IL-10-/- mice during WNV infection, and surviving IL-10-/- mice appeared active and healthy at the end of our infection experiments. It may be feasible to temporally block or reduce IL-10 signaling in the early phase of acute WNV infection to stimulate the patient's anti-viral immune responses without causing severe immunopathological side-effects. Of course, further pre-clinical studies focused on blocking IL-10 signaling as a therapeutic strategy against WNV infection would need to be explored both in terms of safety and efficacy before moving forward into clinical trials.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Experimental animals and virus infection
###end title 49
###begin p 50
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 17 9 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tiger</italic>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Kamanaka1">[40]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Anderson1">[64]</xref>
###xml 549 551 549 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 884 888 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Daffis2">[32]</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 114 119 <span type="species:ncbi:9694">tiger</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:11082">LD50</span>
###xml 567 570 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 679 682 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 739 745 <span type="species:ncbi:9913">bovine</span>
###xml 820 823 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
C57BL/6, IL-10-/-and RAG1-/- mice were purchased from the Jackson Laboratory (Bar Harbor, ME). IL-10-GFP knock-in tiger mice were generated in the laboratory of R. A. Flavell as previously described [40], and were bred as heterozygotes. We performed all experiments on 7-8 week-old mice, and mouse groups were rigorously age- and sex-matched for each infection experiment. West Nile viral isolate 2471 [64] used in these studies was propagated one time in Vero cells and titered in a Vero cell plaque-formation assay. We inoculated mice i.p. with LD50 (2,000 pfu) of WNV isolate 2741 in 100 microl of PBS with 5% gelatin. We performed footpad inoculation by injecting 100 pfu of WNV diluted in 50 microl PBS with 1% heat-inactivated fetal bovine serum (FBS) and conducted intracranial inoculation by injecting 20 pfu of WNV in 20 microl PBS with 1% FBS according to a previous report [32]. We observed mice for up to 21 days after infection and checked them twice daily for morbidity (including lethargy, anorexia, and difficulty ambulating) and mortality. All animal experimental protocols were approved by the Yale University Institutional Animal Care & Use Committee. All animal infection experiments were performed in a Bio-safety Level 3 animal facility, according to the regulations of Yale University.
###end p 50
###begin title 51
Cytokine PCR array
###end title 51
###begin p 52
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 231 232 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 374 375 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 375 393 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Profiler&#8482;</italic>
###xml 606 609 591 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 601 609 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 816 817 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 955 958 936 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 950 958 931 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 125 128 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
One million peritoneal thioglycollate-elicited macrophages were prepared from wild-type or IL-10-/- mice and challenged with WNV isolate 2741 (MOI = 1) in 6-well culture plates in 2 ml of medium and incubated in a 37degreesC, 5% CO2 incubator. Macrophages were collected at 24 h after washes with PBS for total RNA extraction by Qiagen RNeasy Mini kit (Valencia, CA). The RT2Profilertrade mark PCR Array kits were purchased from SuperArray Bioscience Corporation (Frederick, MD), and all assay procedures were conducted in accordance with the kit user manual. Briefly, one microgram of total RNA from IL-10-/- or wild-type macrophages was transcribed into first strand cDNA and loaded into 96-well PCR array plates with 25 microL Q-PCR master mix per well. After performing Q-PCR, resulting threshold cycle values (Ct) for all genes were exported into the company-provided data analysis template Excel files for comparison of gene expression between IL-10-/- and wild-type macrophages. The Q-PCR array experiments were repeated three times with similar results.
###end p 52
###begin title 53
Q-PCR and plaque-formation assay
###end title 53
###begin p 54
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Bai1">[65]</xref>
###xml 404 414 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 516 526 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 664 668 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Bai2">[66]</xref>
###xml 237 240 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Total RNA was extracted from macrophages, blood, spleen and brain tissue using the RNeasy kit (Qiagen, Valencia, CA). RNA was used to synthesize cDNA by the AffinityScript Multi Temperature cDNA synthesis kit (Stratagene, La Jolla, CA). WNV-specific RNA was quantified using a Q-PCR technique as we previously reported [65]. Cytokine gene and viral gene copy number were expressed as a ratio to cellular beta-actin cDNA copies measured by Q-PCR. The ratio of the amount of amplified gene compared with the amount of beta-actin cDNA represented the relative levels in each sample. Plaque-formation assay procedures were carried out according to our previous report [66].
###end p 54
###begin title 55
Confocal microscopy
###end title 55
###begin p 56
###xml 905 908 883 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 911 914 889 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">594</sub>
###xml 924 927 902 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">647</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 750 753 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Mice were sacrificed under isofluorane anesthesia and transcardially perfused with 60 ml of ice-cold PBS. Brains were rapidly isolated and immersion fixed in 4% PFA in PBS overnight at 4degreesC, and cryoprotected in a graded series of sucrose (10%, 20%, and 30%, each overnight at 4degreesC). Para-median sagittal sections were cut at 25 microm using a cryostat. Tissue sections were PAP pen (Zymed Laboratories, South San Francisco, CA) applied and pre-blocked in serum-free protein block (Dakocytomation, Denmark) for 30 min at ambient temperature. Sections were then labeled overnight at 4degreesC with various combinations of primary antibodies against CD11b (1:200, Serotec, Raleigh, NC), CD45 (1:200, Serotec), MAP2 (1:500, Invitrogen) and/or WNV antigen (from J. F. Anderson; 1:250). After three rinses in PBS, sections were labeled with appropriate secondary antibodies conjugated with AlexaFluor488, -594, and/or -647 for 1 h at ambient temperature. Following three additional rinses in PBS sections were mounted in fluorescence mounting medium (ProLong Gold, Invitrogen). Images were acquired in independent channels using a Nikon C1 Eclipse laser scanning confocal microscope.
###end p 56
###begin title 57
Interferon bioassay
###end title 57
###begin p 58
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Samuel2">[67]</xref>
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 575 579 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Daffis3">[68]</xref>
###xml 647 650 641 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">492</sub>
###xml 708 711 702 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">492</sub>
###xml 743 746 737 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">492</sub>
###xml 773 776 767 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">492</sub>
###xml 77 81 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 334 338 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 685 689 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 719 723 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 750 754 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 784 788 <span type="species:ncbi:12104?1.0">EMCV</span>
Type I IFN activity in medium or plasma was detected and quantified using an EMCV bioassay of L929 cells as described [67]. Briefly, serially diluted samples were applied to monolayers of L929 cells (2x106 cells/well) in DMEM containing 10% FBS in 96-well plates. Following incubation for 14 h at 37degreesC, cells were infected with EMCV. Cells were inspected for cytopathic effects, and 7 h p.i., IFN-mediated protection was assayed using a CellTiter 96 aqueous cell proliferation assay (Promega, Madison, WI). The percentage of protected cells was calculated as described [68], according to the following formula: (optical density at 492 nm [OD492] of plasma or supernatant-treated EMCV-infected cells/(OD492 of non-EMCV-infected cells - OD492 of EMCV-infected cells)/OD492 of non-EMCV-infected cells)x100%).
###end p 58
###begin title 59
Cell preparation and culture conditions
###end title 59
###begin p 60
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 276 279 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 367 370 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 452 455 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Mouse peritoneal macrophages were elicited by i.p. injection with 1 ml of thioglycollate medium (BD BBLtrade mark, Franklin Lakes, NJ) and macrophages were collected 3 days later and cultured in DMEM containing 10% FBS and antibiotics. Splenocytes were prepared from naive or WNV-infected mice at selected time points and cultured in RPMI 1640 medium and infected by WNV (MOI = 0.5) or stimulated with 50 ng/ml of PMA (Sigma-Aldrich, St. Louis, MO) or WNV NS4b peptide (SSVWNTATTAI, 1.0 microg/ml). Cell supernatants were collected for cytokine ELISA analysis using kits purchased from R&D Systems (Minneapolis, MN).
###end p 60
###begin title 61
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo monoclonal antibody treatment
###end title 61
###begin p 62
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 192 195 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 564 567 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Seven-week-old female C57BL/6 mice were i.p. injected with 250 microg of mouse anti-IL10r (clone 1B1.3a) or isotype-matched IgG1 (clone R3-34) antibodies in 100 microl of PBS one day prior to WNV infection. Anti-IL10r mAb and isotype control antibodies were purchased from BD Bioscience Pharmingen (San Diego, CA). In anti-IL-10 mAb immunotherapeutic experiments, two doses of 200 microg antibody (clone JES052A5) or isotype control IgG1 (clone 43414, R&D Systems) in 100 microl PBS were injected i.p. daily, with the first dose starting on either day 2 or 4 post-WNV infection.
###end p 62
###begin title 63
Extracellular and intracellular immunostaining
###end title 63
###begin p 64
###xml 166 167 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 471 475 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000610-Selin1">[69]</xref>
###xml 522 523 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 50 53 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 597 600 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1154 1157 <span type="species:ncbi:10116">rat</span>
To measure IFN-gamma production, splenocytes from WNV-infected mice were isolated and cultured under one of two conditions. Half of the samples were incubated at 3x106 cells/tube at room temperature with no exogenous stimulation for 4 h and Golgi-plug (BD Bioscience Pharmingen, 1.0 microg/ml) was added for the final 2 h (BD Bioscience Pharmingen). We used conditions previously described as optimal for spontaneous accumulation of cytokines after removal from the host [69]. The remaining samples were stimulated at 3x106 cells/tube with 50 ng/ml of PMA (Sigma-Aldrich) or with 1.0 microg/ml of WNV NS4b peptide and 500 ng/ml of ionomycin (Sigma-Aldrich) for 4 h at 37degreesC and Golgi-plug (1.0 microg/ml) was added during the final 2 h. Cells were then harvested and stained with the following cell surface antibodies (all were obtained from BD Biosciences Pharmingen): CD3 (clone 500A2), CD4 (clone RM4-5), CD8 (clone 53-6.7), CD11b (M1/70), or CD19 (1D3) and fixed in 4% PFA. Cells were then permeabilized with 0.5% saponin before adding FITC-conjugated anti-IFN-gamma mAb (BD Bioscience Pharmingen, CA) or isotype-matched control FITC-conjugated rat IgG1 for intracellular staining.
###end p 64
###begin title 65
Splenocyte adoptive transfer
###end title 65
###begin p 66
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10<sup>&#8722;/&#8722;</sup></italic>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAG1<sup>&#8722;/&#8722;</sup></italic>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
Splenic single cell suspensions were prepared from naive C57BL/6 or IL-10-/- mice and CD4+ T cells were positively selected using anti-mouse CD4 (L3T4)-conjugated microbeads (Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions and the purity of eluted cells was assessed by flow cytometry analysis. RAG1-/- mice received 1x107 CD4+ T cells (>98% purity) in 200 microl of PBS per mouse or PBS alone as control.
###end p 66
###begin title 67
Statistical analysis
###end title 67
###begin p 68
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We calculated standard errors of the means (SEM) and analyzed data by non-paired Student's t-test for single mean comparisons. We performed survival curve comparisons using the log-rank test (GraphPad Prism 4.0, La Jolla, CA). p<0.05 was considered as statistically significant for all analyses.
###end p 68
###begin title 69
Accession numbers
###end title 69
###begin p 70
IL-10 (MGI 96537, PF 00726); WNVE (AF 206518); IFN-alpha (M 68944); IFN-beta (NM 010510); IFN-gamma (NM 008337); TNF-alpha (MGI 104798); IL-12/23 p40 (MGI 96540); Rag1 (MGI 97848); Actb (MGI 87904).
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 14 17 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 126 129 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
Reduced brain WNV infection and CD11b+ innate immune cells in IL-10-/- mice. Perfused brains were isolated on day 7 p.i., and WNV antigen (green signal), CD11b (red signal) and neurons (MAP2, blue signal) were detected by confocal microscopy. These images represent 9 mice per group in 3 independent experiments, in which similar results were obtained.
###end p 72
###begin p 73
(5.16 MB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 54 57 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 103 106 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
We are grateful to Dr. John F. Anderson for providing WNV and the mouse ascites fluid antibody against WNV antigen, and to Dr. Yisong Wan for helpful discussion. We thank Xianzhong Liu and Deborah Beck for expert technical assistance. T. Town is the inaugural holder of the Ben Winters Endowed Chair in Regenerative Medicine. E. Fikrig and R. A. Flavell are investigators with the Howard Hughes Medical Institute.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
West Nile virus: a primer for the clinician.
###end article-title 77
###begin article-title 78
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
West Nile virus: a growing concern?
###end article-title 78
###begin article-title 79
Interleukin-10 and the interleukin-10 receptor.
###end article-title 79
###begin article-title 80
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Interleukin-10-deficient mice develop chronic enterocolitis.
###end article-title 80
###begin article-title 81
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 63 80 <span type="species:ncbi:5811">Toxoplasma gondii</span>
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
###end article-title 81
###begin article-title 82
###xml 41 59 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.
###end article-title 82
###begin article-title 83
Resolution of a chronic viral infection after interleukin-10 receptor blockade.
###end article-title 83
###begin article-title 84
Interleukin-10 determines viral clearance or persistence in vivo.
###end article-title 84
###begin article-title 85
Interleukin-10 plays an early role in generating virus-specific T cell anergy.
###end article-title 85
###begin article-title 86
###xml 30 45 <span type="species:ncbi:11082">West Nile virus</span>
Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.
###end article-title 86
###begin article-title 87
###xml 46 61 <span type="species:ncbi:11082">West Nile virus</span>
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
###end article-title 87
###begin article-title 88
###xml 76 91 <span type="species:ncbi:11082">West Nile virus</span>
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.
###end article-title 88
###begin article-title 89
###xml 111 126 <span type="species:ncbi:11082">West Nile virus</span>
Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.
###end article-title 89
###begin article-title 90
###xml 102 117 <span type="species:ncbi:11082">West Nile virus</span>
Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors.
###end article-title 90
###begin article-title 91
###xml 52 67 <span type="species:ncbi:11082">West Nile virus</span>
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
###end article-title 91
###begin article-title 92
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.
###end article-title 92
###begin article-title 93
###xml 35 50 <span type="species:ncbi:11082">West Nile virus</span>
Role of CD8+ T cells in control of West Nile virus infection.
###end article-title 93
###begin article-title 94
###xml 39 54 <span type="species:ncbi:11082">West Nile virus</span>
CD8+ T cells require perforin to clear West Nile virus from infected neurons.
###end article-title 94
###begin article-title 95
###xml 43 58 <span type="species:ncbi:11082">West Nile virus</span>
CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.
###end article-title 95
###begin article-title 96
###xml 63 78 <span type="species:ncbi:11082">West Nile virus</span>
Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.
###end article-title 96
###begin article-title 97
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
###end article-title 97
###begin article-title 98
###xml 54 69 <span type="species:ncbi:11082">West Nile virus</span>
Role of two distinct gammadelta T cell subsets during West Nile virus infection.
###end article-title 98
###begin article-title 99
###xml 57 72 <span type="species:ncbi:11082">West Nile virus</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.
###end article-title 99
###begin article-title 100
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 60 75 <span type="species:ncbi:11082">West Nile virus</span>
IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection.
###end article-title 100
###begin article-title 101
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages.
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes.
###end article-title 102
###begin article-title 103
###xml 68 73 <span type="species:ncbi:9606">human</span>
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.
###end article-title 103
###begin article-title 104
###xml 19 24 <span type="species:ncbi:9606">human</span>
IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4.
###end article-title 104
###begin article-title 105
###xml 24 29 <span type="species:ncbi:9606">human</span>
Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.
###end article-title 105
###begin article-title 106
###xml 57 62 <span type="species:ncbi:9606">human</span>
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.
###end article-title 106
###begin article-title 107
Icam-1 participates in the entry of west nile virus into the central nervous system.
###end article-title 107
###begin article-title 108
###xml 51 66 <span type="species:ncbi:11082">West Nile virus</span>
Toll-like receptor 3 has a protective role against West Nile virus infection.
###end article-title 108
###begin article-title 109
Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing.
###end article-title 109
###begin article-title 110
###xml 30 45 <span type="species:ncbi:11082">West Nile virus</span>
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
###end article-title 110
###begin article-title 111
###xml 21 36 <span type="species:ncbi:11082">West Nile virus</span>
Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis.
###end article-title 111
###begin article-title 112
###xml 83 98 <span type="species:ncbi:11082">West Nile virus</span>
Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.
###end article-title 112
###begin article-title 113
###xml 64 79 <span type="species:ncbi:11082">West Nile virus</span>
Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
###end article-title 113
###begin article-title 114
Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.
###end article-title 114
###begin article-title 115
IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.
###end article-title 115
###begin article-title 116
###xml 102 107 <span type="species:ncbi:9694">tiger</span>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.
###end article-title 116
###begin article-title 117
Interleukin-10 and related cytokines and receptors.
###end article-title 117
###begin article-title 118
IL-10: the master regulator of immunity to infection.
###end article-title 118
###begin article-title 119
###xml 85 102 <span type="species:ncbi:11103">hepatitis C virus</span>
Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.
###end article-title 119
###begin article-title 120
###xml 0 3 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 84 95 <span type="species:ncbi:11103">hepatitis C</span>
HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.
###end article-title 120
###begin article-title 121
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.
###end article-title 121
###begin article-title 122
###xml 98 126 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
###end article-title 122
###begin article-title 123
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
###end article-title 123
###begin article-title 124
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.
###end article-title 124
###begin article-title 125
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.
###end article-title 125
###begin article-title 126
###xml 39 54 <span type="species:ncbi:11082">West Nile virus</span>
Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.
###end article-title 126
###begin article-title 127
###xml 75 90 <span type="species:ncbi:11082">West Nile virus</span>
###xml 109 112 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).
###end article-title 127
###begin article-title 128
###xml 133 148 <span type="species:ncbi:11082">West Nile virus</span>
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
###end article-title 128
###begin article-title 129
Immune modulation by flaviviruses.
###end article-title 129
###begin article-title 130
###xml 118 140 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.
###end article-title 130
###begin article-title 131
###xml 37 59 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice.
###end article-title 131
###begin article-title 132
###xml 32 37 <span type="species:ncbi:9606">human</span>
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
###end article-title 132
###begin article-title 133
IL-10 inhibits cytokine production by activated macrophages.
###end article-title 133
###begin article-title 134
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.
###end article-title 134
###begin article-title 135
Interleukin 10: an overview.
###end article-title 135
###begin article-title 136
###xml 52 67 <span type="species:ncbi:11082">West Nile virus</span>
Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.
###end article-title 136
###begin article-title 137
###xml 0 15 <span type="species:ncbi:11082">West Nile virus</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier.
###end article-title 137
###begin article-title 138
###xml 89 104 <span type="species:ncbi:11082">West Nile virus</span>
Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.
###end article-title 138
###begin article-title 139
###xml 81 96 <span type="species:ncbi:11082">West Nile virus</span>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain.
###end article-title 139
###begin article-title 140
###xml 13 28 <span type="species:ncbi:11082">West Nile virus</span>
Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.
###end article-title 140
###begin article-title 141
###xml 42 48 <span type="species:ncbi:10090">murine</span>
Use of RNA interference to prevent lethal murine west nile virus infection.
###end article-title 141
###begin article-title 142
Antiviral peptides targeting the west nile virus envelope protein.
###end article-title 142
###begin article-title 143
PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.
###end article-title 143
###begin article-title 144
###xml 46 61 <span type="species:ncbi:11082">West Nile virus</span>
Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.
###end article-title 144
###begin article-title 145
###xml 39 53 <span type="species:ncbi:10245">vaccinia virus</span>
Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
###end article-title 145
###begin p 146
The authors have declared that no competing interests exist.
###end p 146
###begin p 147
This study was funded by the NIH grants N01-AI-50031 and AI 070343. FB was supported by a career development grant (U54-AI057158-Lipkin). TT is supported by an NIH/NIA "Pathway to Independence" award (4R00AG029726-02 and 5R00AG029726-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 147

